Evaluation of APC resistance in the plasma of patients with Q506 mutation of factor V (factor V Leiden) and treated by oral anticoagulants
Cadroy, Y.; Sié, P.; Alhenc-Gelas, M.; Aiach, M.
Thrombosis and Haemostasis 73(4): 734-735
1995
ISSN/ISBN: 0340-6245 PMID: 7495093 Document Number: 442395
Document emailed within 1 workday
Related Documents
Van Wijk, E.M.; Kahlé, L.H.; ten Cate, J.W. 1980: Mechanized amidolytic technique for determination of factor X and factor-X antigen, and its application to patients being treated with oral anticoagulants Clinical Chemistry 26(7): 885-8902001: Summaries for patients. Blood clots in people with the factor V Leiden mutation Annals of Internal Medicine 135(5): S-34
Verheggen, P.W.; Heymans, B.T.; Slagboom, P.E.; Haverkate, F.; Cats, V.M. 1997: Normal prevalence of factor V Leiden gene mutation in patients with severe unstable angina Thrombosis and Haemostasis 77(6): 1218
Schröder, W.; Koessling, M.; Wulff, K.; Wehnert, M.; Herrmann, F.H. 1996: World distribution of factor V Leiden mutation Lancet 347(8993): 58-59
Fouéré, S.; Guibal, F.; Morel, P. 1996: World distribution of factor V Leiden mutation Lancet 347(8993): 59
Kotaka, M.; Kohchi, A. 2003: Perioperative management of a patient with factor V Leiden mutation Masui. Japanese Journal of Anesthesiology 52(4): 409-411
Paseka, J.; Unzeitig, V.; Cibula, D.; Buliková, A.; Matýsková, M.; Chroust, K. 2000: The factor V Leiden mutation in users of hormonal contraceptives Ceska Gynekologie 65(3): 156-159
Yong, A.Anning.; Tan, A.Wei.Hsia.; Giam, Y.Chin.; Tang, M.Boon.Yang. 2012: Livedoid vasculopathy and its association with factor V Leiden mutation Singapore medical journal 53(12): e258-e260
Billon, S.; Escoffre-Barbe, M.; Mercier, B.; Abgrall, J.F.; Ferec, C. 1999: Fibrinogen is not an additional risk factor of thromboembolic disease in factor V Leiden patients Thrombosis and Haemostasis 81(4): 659-660
Dahlbäck, B. 1997: Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis Thrombosis and Haemostasis 78(1): 483-488
Melegh, B.; Stankovics, J.; Kis, A.; Nagy, A.; Storcz, J.; Losonczy, H.; Méhes, K. 1998: Increased prevalence of factor V Leiden mutation in neonatal intracranial haemorrhage European Journal of Pediatrics 157(3): 261
Morissette, N.; Gorman, T. 2010: Antiphospholipid syndrome and homozygous factor V Leiden mutation in a young patient with Libman-Sacks endocarditis and stroke American Journal of Medicine 123(9): E3-E4
Castoldi, E.; Kalafatis, M.; Lunghi, B.; Simioni, P.; Ioannou, P.A.; Petio, M.; Girolami, A.; Mann, K.G.; Bernardi, F. 1998: Molecular bases of pseudo-homozygous APC resistance: the compound heterozygosity for FV R506Q and a FV null mutation results in the exclusive presence of FV Leiden molecules in plasma Thrombosis and Haemostasis 80(3): 403-406
Narawane, N.M.; Phadke, A.Y.; Shah, S.K.; Bhandarkar, P.V.; Abraham, P. 2000: Jejunal stricture complicating acute mesenteric venous thrombosis secondary to protein C deficiency and factor V Leiden gene mutation Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 19(2): 79-80
Négrier, C.; Shapiro, A.; Berntorp, E.; Pabinger, I.; Tarantino, M.; Retzios, A.; Schroth, P.; Ewenstein, B. 2008: Surgical evaluation of a recombinant factor VIII prepared using a plasma/albumin-free method: efficacy and safety of Advate in previously treated patients Thrombosis and Haemostasis 100(2): 217-223
Leroy-Matheron, C.; Levent, M.; Pignon, J.M.; Mendonça, C.; Gouault-Heilmann, M. 1996: The 1691 G-->A mutation in the factor V gene: relationship to activated protein C (APC) resistance and thrombosis in 65 patients Thrombosis and Haemostasis 75(1): 4-10
Bertina, R.M. 1997: Factor V Leiden and other coagulation factor mutations affecting thrombotic risk Clinical Chemistry 43(9): 1678-1683
Rolla, R.; Vidali, M.; Meola, S.; Pollarolo, P.; Pergolini, P.; Bellomo, G. 2011: Estimating the Cost of Redundancy in Molecular Diagnostics: The Case of Activated Protein C Resistance and Factor V Leiden Clinical Laboratory 57(9-10): 711-717
Aksoy, M.; Tek, I.; Karabulut, H.; Berker, B.; Soylemez, F. 2005: The role of thrombofilia related to Factor V Leiden and Factor II G20210A mutations in recurrent abortions Jpma. Journal of the Pakistan Medical Association 55(3): 104-108
Mercuri, F.; Giacomello, R.; Puglisi, F.; Colaone, R.; Fabbro, D.; Menegon, M.G.; Ceriello, A.; Gonano, F.; Damante, G. 2000: Factor V leiden increases plasma F1+2 levels both in normal and deep venous thrombosis subjects Haematologica 85(4): 386-389